
(AGENPARL) – ROME sab 13 maggio 2023 The aim of the project is to improve the company’s new COVID-19 PCR-based rapid test and to develop rapid tests against other infectious diseases, such as the ones caused by respiratory or antibiotic-resistant pathogens.
Fonte/Source: https://www.eib.org/en/projects/pipelines/all/20180826